Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL258246 | 0.95 | PTGS1 (0.56) | LTA4HPTGS1TRPV1EPHX2TSHR | |
| SCHEMBL27519166 | 0.85 | CA2 (0.52) | LTA4HEPHX2 | |
| SCHEMBL258247 | 0.83 | PTGS1 (0.57) | LTA4HPTGS1TRPV1TSHRPPARG | |
| SCHEMBL258332 | 0.83 | PTGS1 (0.57) | LTA4HPTGS1TRPV1TSHRPPARG | |
| SCHEMBL2208675 | 0.82 | LTA4H (0.56) | LTA4HPTGS1TRPV1EPHX2 | |
| SCHEMBL15259685 | 0.81 | CALM1 (0.50) | TSHR | |
| SCHEMBL4383898 | 0.81 | S1PR2 (0.52) | EPHX2 | |
| Acetic Acid SCHEMBL28382089 | 0.81 | CYP1A2 (0.56) | LTA4HTRPV1TSHR | |
| SCHEMBL8337378 | 0.80 | CA2 (0.53) | EPHX2PPARGPPARA | |
| SCHEMBL102358 | 0.80 | MGLL (0.58) | LTA4HPTGS1TRPV1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1517880-B1 | PRODUCTION OF CIS-PELLITORIN AND USE AS A FLAVOURING | SYMRISE AG (DE) | 2011-01-05 | — | — | EP | claimed |
| EP-4699452-A2 | OBTAINING A VOLATILE FRACTION FROM JUICES OR ALCOHOLIC BEVERAGES | Symrise AG (DE) | 2026-02-25 | — | — | EP | disclosed |
| US-20260041109-A1 | ROBUST FLAVOR EMULSIONS | INT FLAVORS & FRAGRANCES INC (US) | 2026-02-12 | — | — | US | disclosed |
| EP-3836799-B1 | OBTAINING A VOLATILE FRACTION FROM JUICES OR ALCOHOLIC BEVERAGES | SYMRISE AG (DE) | 2025-11-26 | — | — | EP | disclosed |
| US-12419815-B2 | Microcapsule compositions stabilized with viscosity control agents | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-09-23 | — | — | US | disclosed |
| US-12357547-B2 | Compositions containing microcapsules | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-07-15 | — | — | US | disclosed |
| US-12324452-B2 | Delivery systems and methods of preparing the same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-06-10 | — | — | US | disclosed |
| US-12274771-B2 | Polyurea capsule compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-04-15 | — | — | US | disclosed |
| US-12030326-B2 | System and method for printing and drying flavors and fragrances | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240180220-A1 | HYDROGEL ENCAPSULATIONS AND METHODS OF MAKING THE SAME | INTERNATIONAL FLAVORS & FRANGRANCES INC. | 2024-06-06 | — | — | US | disclosed |
| EP-1682489-A1 | USE OF ALKENE CARBOXLIC ACID N ALKYLAMIDES AS FLAVOURING AGENTS | Symrise GmbH & Co. KG (DE) | 2006-07-26 | — | — | EP | disclosed |
| WO-2006003210-A1 | USE OF ALKYLOXYALCANIC ACID AMIDES, IN PARTICULAR IN THE FORM OF AROMATIC SUBSTANCES AND A NOVEL ALKYLOXYALCANIC ACID AMIDE | SYMRISE GMBH & CO. KG (DE) | 2006-01-12 | — | — | WO | disclosed |
| EP-1562893-A2 | USE OF TRANS-PELLITORIN IN THE FORM OF AN AROMATIC SUBSTANCE | Symrise GmbH & Co. KG (DE) | 2005-08-17 | — | — | EP | disclosed |
| WO-2005044778-A1 | USE OF ALKENE CARBOXLIC ACID N ALKYLAMIDES AS FLAVOURING AGENTS | SYMRISE GMBH & CO. KG (DE) | 2005-05-19 | — | — | WO | disclosed |
| EP-1517880-A2 | PRODUCTION OF CIS-PELLITORIN AND USE AS A FLAVOURING | Symrise GmbH & Co. KG (DE) | 2005-03-30 | — | — | EP | disclosed |
| EP-1515943-A1 | USE OF ALKYLAMIDOMANDELATES AS FLAVOURINGS | Symrise GmbH & Co. KG (DE) | 2005-03-23 | — | — | EP | disclosed |
| US-20040241312-A1 | Use of 2E,4E-decadienoic acid isobutylamide for imparting a salivation inducing effect to a foodstuff, an oral hygiene preparation or a gourmet or snack preparation; preparation by amidating a dodecadienoate with isobutylamine | SYMRISE AG (DE) | 2004-12-02 | — | — | US | disclosed |
| WO-2004043906-A2 | USE OF TRANS-PELLITORIN IN THE FORM OF AN AROMATIC SUBSTANCE | SYMRISE GMBH & CO. KG (DE) | 2004-05-27 | — | — | WO | disclosed |
| WO-2004000787-A2 | PRODUCTION OF CIS-PELLITORIN AND USE AS A FLAVOURING | SYMRISE GMBH & CO. KG (DE) | 2003-12-31 | — | — | WO | disclosed |
| WO-2003106404-A1 | USE OF ALKYLAMIDOMANDELATES AS FLAVOURINGS | SYMRISE GMBH & CO. KG (DE) | 2003-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12357547-B2 | Compositions containing microcapsules | COPE, SAAL1, AUP1 | LTA4H 1613/4885PTGS1 4417/4885TRPV1 4192/4885 |
| US-12324452-B2 | Delivery systems and methods of preparing the same | MAL2, TAS2R42, TAS2R31 | LTA4H 303/4885PTGS1 1476/4885TRPV1 749/4885 |
| US-12419815-B2 | Microcapsule compositions stabilized with viscosity control agents | ACR, ALG1, MLEC | LTA4H 1355/4885PTGS1 3366/4885TRPV1 3271/4885 |
| US-12274771-B2 | Polyurea capsule compositions | PUF60, UMPS, PCBP1 | LTA4H 3753/4885PTGS1 3400/4885TRPV1 3537/4885 |
| US-20260041109-A1 | ROBUST FLAVOR EMULSIONS | ACACA, FABP4, CUTA | LTA4H 3142/4885PTGS1 2811/4885TRPV1 687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.